Central Asia: Market for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof 2024

Market Size for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Central Asia

In 2022, after three years of growth, there was decline in the Central Asian penicillins or streptomycins medicaments market, when its value decreased by -2% to $X. In general, consumption continues to indicate a buoyant expansion. The level of consumption peaked at $X in 2021, and then reduced in the following year.

Production of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Central Asia

In value terms, penicillins or streptomycins medicaments production rose rapidly to $X in 2022 estimated in export price. Over the period under review, production posted a significant increase. The pace of growth was the most pronounced in 2013 when the production volume increased by 2,466%. Over the period under review, production reached the peak level at $X in 2014; however, from 2015 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

Exports in Central Asia

Penicillins or streptomycins medicaments exports soared to X tons in 2022, growing by 109% against 2021. Overall, exports enjoyed significant growth. The pace of growth was the most pronounced in 2015 with an increase of 706% against the previous year. The volume of export peaked at X tons in 2020; however, from 2021 to 2022, the exports stood at a somewhat lower figure.

In value terms, penicillins or streptomycins medicaments exports skyrocketed to $X in 2022. Over the period under review, exports enjoyed a significant expansion. The most prominent rate of growth was recorded in 2015 with an increase of 1,118%. Over the period under review, the exports attained the peak figure at $X in 2020; however, from 2021 to 2022, the exports failed to regain momentum.

Exports by Country

The biggest shipments were from Uzbekistan (X tons) and Kazakhstan (X tons), together resulting at 99.9% of total export.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the leading exporting countries, was attained by Kazakhstan (with a CAGR of +17.5%).

In value terms, Kazakhstan ($X) emerged as the largest penicillins or streptomycins medicaments supplier in Central Asia, comprising 73% of total exports. The second position in the ranking was taken by Uzbekistan ($X), with a 26% share of total exports.

In Kazakhstan, penicillins or streptomycins medicaments exports increased at an average annual rate of +18.7% over the period from 2012-2022.

Export Prices by Country

The export price in Central Asia stood at $X per ton in 2022, stabilizing at the previous year. Over the period under review, the export price saw a noticeable descent. The growth pace was the most rapid in 2019 an increase of 116%. The level of export peaked at $X per ton in 2015; however, from 2016 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Kazakhstan ($X per ton), while Uzbekistan amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kazakhstan (+1.1%).

Imports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

Imports in Central Asia

In 2022, approx. X tons of medicaments of penicillins, streptomycins or derivatives thereof were imported in Central Asia; increasing by 14% against the previous year's figure. Overall, imports showed a remarkable increase. The pace of growth was the most pronounced in 2017 with an increase of 131%. The volume of import peaked in 2022 and is expected to retain growth in the near future.

In value terms, penicillins or streptomycins medicaments imports contracted to $X in 2022. In general, imports recorded a remarkable increase. The most prominent rate of growth was recorded in 2017 when imports increased by 102% against the previous year. Over the period under review, imports hit record highs at $X in 2021, and then contracted in the following year.

Imports by Country

In 2022, Uzbekistan (X tons), distantly followed by Tajikistan (X tons), Kazakhstan (X tons), Kyrgyzstan (X tons) and Turkmenistan (X tons) represented the major importers of medicaments of penicillins, streptomycins or derivatives thereof, together creating 96% of total imports. Mongolia (X tons) followed a long way behind the leaders.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Tajikistan (with a CAGR of +6.6%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Uzbekistan ($X), Kazakhstan ($X) and Mongolia ($X) appeared to be the countries with the highest levels of imports in 2022, with a combined 77% share of total imports.

Among the main importing countries, Uzbekistan, with a CAGR of +9.6%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Central Asia stood at $X per ton in 2022, with a decrease of -19.6% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of +1.3%. The pace of growth appeared the most rapid in 2015 an increase of 25%. The level of import peaked at $X per ton in 2020; however, from 2021 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Mongolia ($X per ton), while Tajikistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Mongolia (+12.2%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :